ArticleVaccines2022

SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.

Anna V Vakhrusheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.